Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Cipla
US Department of Justice
Federal Trade Commission
Merck

Generated: March 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Combretastatin

« Back to Dashboard

US Patents for Combretastatin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Combretastatin ➤ Try a Free Trial Anti-FGFR3 antibodies and methods using same Genentech, Inc. (South San Francisco, CA) ➤ Try a Free Trial
Combretastatin ➤ Try a Free Trial Method of diagnosing and treating cancer using B-catenin splice variants The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) ➤ Try a Free Trial
Combretastatin ➤ Try a Free Trial Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) ➤ Try a Free Trial
Combretastatin ➤ Try a Free Trial Use of inhibitors of Bruton'S tyrosine kinase (Btk) Pharmacyclics LLC (Sunnyvale, CA) ➤ Try a Free Trial
Combretastatin ➤ Try a Free Trial Use of inhibitors of Bruton's tyrosine kinase (Btk) Pharmacyclics LLC (Sunnyvale, CA) ➤ Try a Free Trial
Combretastatin ➤ Try a Free Trial Inhibition of hypoxia-inducible factor activity with carica papaya extracts The Regents of the University of California (Oakland, CA) Universiti Putra Malaysia (Selangor Darul Ehsan, MY) ➤ Try a Free Trial
Combretastatin ➤ Try a Free Trial Therapeutic compositions and methods for antibody and Fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells VAXIION THERAPEUTICS, LLC (San Diego, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Combretastatin

Drugname Country Document Number Estimated Expiration Related US Patent
Combretastatin Argentina 075939 2029-03-25 ➤ Try a Free Trial
Combretastatin Australia 2010229994 2029-03-25 ➤ Try a Free Trial
Combretastatin Canada 2754163 2029-03-25 ➤ Try a Free Trial
Combretastatin China 102378767 2029-03-25 ➤ Try a Free Trial
Combretastatin China 104788564 2029-03-25 ➤ Try a Free Trial
Combretastatin Colombia 6450665 2029-03-25 ➤ Try a Free Trial
Combretastatin Denmark 2411414 2029-03-25 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
Boehringer Ingelheim
Fish and Richardson
Merck
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.